News
Health Matters: Health Canada approves Ozempic to help reduce kidney decline
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 diabetes. The decision comes after an international clinical trial found the risk of deteriorating kidney function was 24 per cent lower in patients taking Ozempic compared to those taking a placebo injection.
Ozempic and Rybelsus are both approved by Health Canada to treat adults withType 2 diabetes. Some doctors also prescribe them "off-label" to treat obesity in some patients.
Rush for diabetes and weight-loss drug Ozempic puts cross-border sales in spotlight By: Darryl Greer, The Canadian Press Posted: 4:25 PM CDT Thursday, Mar. 30, 2023 Last Modified: 6:47 PM CDT ...
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, ...
The lower-dose Ozempic injection pens of 0.25 mg and 0.5 mg remain available and "may be an option for some patients" as an alterative, Health Canada's web page said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback